Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.700
+0.050 (3.03%)
At close: May 22, 2026, 4:00 PM EDT
1.730
+0.030 (1.76%)
After-hours: May 22, 2026, 7:56 PM EDT
Autolus Therapeutics Employees
As of December 31, 2025, Autolus Therapeutics had 754 total employees, including 752 full-time and 2 part-time employees. The number of employees increased by 104 or 16.00% compared to the previous year.
Employees
754
Change (1Y)
104
Growth (1Y)
16.00%
Revenue / Employee
$122,844
Profits / Employee
-$383,243
Market Cap
452.44M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 754 | 104 | 16.00% | 752 | 2 |
| Dec 31, 2024 | 650 | 179 | 38.00% | 647 | 3 |
| Dec 31, 2023 | 471 | 67 | 16.58% | 463 | 8 |
| Dec 31, 2022 | 404 | 77 | 23.55% | 399 | 5 |
| Dec 31, 2021 | 327 | -57 | -14.84% | 324 | 3 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| 4D Molecular Therapeutics | 196 |
| ADC Therapeutics | 193 |
| Neurogene | 131 |
| Ocugen | 116 |
| Adlai Nortye | 109 |
| Prelude Therapeutics | 79 |
| Upstream Bio | 75 |
| Fulcrum Therapeutics | 55 |
AUTL News
- 4 days ago - Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026 - GlobeNewsWire
- 11 days ago - Autolus Therapeutics price target raised to $10 from $9 at H.C. Wainwright - TheFly
- 11 days ago - Autolus Therapeutics Q1 Earnings Call Highlights - MarketBeat
- 11 days ago - Autolus Therapeutics reports Q1 EPS (27c), consensus (26c) - TheFly
- 11 days ago - Autolus Therapeutics backs FY26 revenue view $120M-$135M, consensus $129.39M - TheFly
- 11 days ago - Autolus Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 11 days ago - Autolus Therapeutics Earnings release: Q1 2026 - Filings
- 11 days ago - Autolus Therapeutics Quarterly report: Q1 2026 - Filings